Faculty Information   
   日本語 >>
  1. TOP page
    2. >
  2. Central Clinic
    3. >
  3. Inflammatory Bowel Disease Center

Journal
Presentation
    （Last updated : 2023-10-17 12:11:41）
  Takagawa Tetsuya
   Department     Center for Clinical Research and Education, Center for Clinical Research and Education
   Position  
■ Journal
1. Case report　 Early gastric adenocarcinoma of the fundic gland type. 2015/04
2. Original article　 NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases. 2017/07
3. Original article　 An increase in LRRK2 suppresses autophagy and enhances Dectin-1-induced immunity in a mouse model of colitis 2018/06
4. Original article　 Does discontinuation of antithrombotics affect the diagnostic yield of small bowel capsule endoscopy in patients demonstrating obscure gastrointestinal bleeding? 2018/08
5. Original article　 NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter 2018/09
■ Presentation
1. Incidence and Severity of Acute Kidney Injury During Oral Tacrolimus Treatment in Patients With Refractory Ulcerative Colitis （Poster presentation，General Lecture） 2015/05/16
2. Increased Expression of LRRK2,a Susceptibility Gene of IBD Results in Enhanced Pro-Inflammatory Response and Severe Experimental Colitis （Oral presentation，General Lecture） 2015/05/16
3. Disease Extension in Japanese Patients With Ulcerative Colitis and the Clinical Course （Poster presentation，General Lecture） 2015/06/19
4. THE CLINICAL OUTCOMES OF 165 ENDOSCOPIC BALLOON DILATATION FOR ILEOCOLONIC OR CAECAL STRICTURES IN PATIENTS WITH CROHN'S DISEASE （Oral presentation，Symposium/Workshop/Panel Discussion） 2015/10/28
5. Long term efficacy and safety of thiopurines in patients with steroid dependent Ulcerative Colitis: A retrospective investigation （Poster presentation，General Lecture） 2016/03/18
6. Pregnancy outcomes in patients with Inflammatory Bowel Disease experiencing flare ups during foetal development （Poster presentation，General Lecture） 2016/03/18
7. Proximal extension of distal lesions in patients with Ulcerative Colitis （Poster presentation，General Lecture） 2016/03/18
8. The efficacy of infliximab in tacrolomus non-responder with UC （Poster presentation，General Lecture） 2016/03/18
9. LRRK2, a Susceptibility Gene of IBD Suppresses Autophagy Through Beclin-1 Inactivation （Poster presentation，General Lecture） 2016/05/22
10. Factors Associated With Restenosis and the Need for Surgical Interventions in Patients With Crohn`s Disease Undergoing Endoscopic Balloon Dilatation for Lower Gastrointestinal Strictures （Poster presentation，General Lecture） 2016/05/23
11. The endoscopic feature of relapse in ulcerative colitis treated with infliximab. （Poster presentation，General Lecture） 2016/07/08
12. Genetically-Determined Increases in LRRK2 Levels enhance susceptibility to colitis （Poster presentation，General Lecture） 2016/07/09
13. Thiopurine-induced Leukopenia Is Associated with a Variant in NUDT15, but Not FTO and RUNX1 in Japanese Patients with Inflammatory Bowel Diseases. （Oral presentation，General Lecture） 2017/06/17
14. LRRK2 Inhibitor Attenuates Intestinal Inflammation and Becomes a Therapeutic Strategy in Inflammatory Bowel Diseases （Poster presentation，General Lecture） 2017/07/21
15. Clinical and endoscopic features of secondary loss of response caases in patients with Crohns disease treated with infliximab by top down strategy a case control study （Poster presentation，General Lecture） 2018/02/16
16. Clinical characteristics and complications in hospitalised elderly patients with ulcerative colitis in a real world specialised hospital （Poster presentation，General Lecture） 2018/02/16
17. CLINICAL CHARACTERISTICS AND COMPLICATIONS IN HOSPITALISED ELDERLY PATIENTS WITH ULCERATIVE COLITIS IN A REAL-WORLD SPECIALISED HOSPITAL （Poster presentation，General Lecture） 2018/06/04
18. THE INITIAL TROUGH CONCENRTATION AT 36 HOURS AFTER STARTING TACROLIMUS IS IMPORTANT FOR THE PERSONALIZED MEDICINE STRATEGY IN PATIENTS WITH ULCERATIVE COLITIS （Poster presentation，General Lecture） 2018/06/04
19. Clinical features of ulcerative colitis complicated by autoimmune hepatitis: a case series in Japan （Poster presentation，General Lecture） 2018/06/22
20. Efficacy and related issues of cytapheresis in elderly patients with ulcerative colitis （Poster presentation，General Lecture） 2018/06/22
21. Endoscopic features for loss of response in patients with Crohn’s disease who were treated with infliximab by top-down strategy. （Poster presentation，General Lecture） 2019/03/08
22. Investigations of the characteristics and efficary of anti-TNFα agents for optimizing treatment in pediatric patients with new-onset Crhon’s disease. （Poster presentation，General Lecture） 2019/03/08
23. Risk factors and clinical characteristics for Pneumonia in Japanese Patients with Ulcerative Colitis. （Poster presentation，General Lecture） 2019/03/08
24. The initial trough concentration at 36 hours after starting tacrolimus is important for the personalized medicine strategy in patients with ulcerative colitis. （Poster presentation，General Lecture） 2019/03/08
Display 5 items
Display all(24)
mail